ロード中...
Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
It has been >35 years since the link between angiogenesis and the growth of tumors was first reported. Targeting angiogenesis became feasible with the availability of bevacizumab, an anti–vascular endothelial growth factor monoclonal antibody. Initial studies revealed that the combination of beva...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AlphaMed Press
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3227980/ https://ncbi.nlm.nih.gov/pubmed/20427383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0225 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|